Skip to main content
Premium Trial:

Request an Annual Quote

Enzo Biochem Sues Amersham, Orchid, PerkinElmer, over Labeling Technique

NEW YORK, Oct. 23-Enzo Biochem has filed suit against Amersham, PerkinElmer, Orchid Biosciences and two other companies for breach of contract and patent infringement, the company said today.

 

The suit, filed in the U.S. District Court for the Southern District of New York, alleges that these companies have misused Enzo's nucleotide labeling technologies, methods used in gene sequencing and analysis.

 

Amersham Biosciences, PerkinElmer and Sigma-Aldrich, three of the defendants in the suit, had all signed agreements to distribute Enzo's labeled nucleotide products. Enzo claims that these three distributors were permitted only to distribute these products for research use, but violated their agreements by developing the technology for clinical use, exploiting Enzo's patents without authorization.

 

The other defendants, Orchid and Molecular Probes, are charged with patent infringement.

 

Enzo's corporate headquarters are in New York, NY.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.